āshibio, a privately held biotechnology company developing novel therapeutics for treating bone and connective tissue disorders, exited stealth mode with $40 million in seed and Series A financing.

BRISBANE, Calif.--(BUSINESS WIRE)--āshibio, a privately held biotechnology company developing novel therapeutics for the treatment of bone and connective tissue disorders, exited stealth mode today ...

An interdisciplinary team of engineers and chemists has laid the groundwork to 3D print spheroids — tiny clusters of living cells — capable of regenerating bone tissue in response to severe trauma or ...

A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes. The article, "Type 2 Diabetes and ...

To lose weight, most of us know that it is a matter of eating less and being more physically active. By putting our bodies into a calorie deficit, we "burn" more calories than we're taking in—and so ...